Intra‐Islet Paracrine Regulation of Glucagon Secretion During Hypoglycemia, Euglycemia, and Hyperglycemia
Паракринная регуляция секреции глюкагона внутри островка при гипогликемии, эугликемии и гипергликемии
2026-09-01
SCID: 54.1/kjmqmfac
Discuss with AI
glucagon secretioninsulin-induced hypoglycemiaintra-islet paracrine regulationpancreatic α-cellssomatostatin receptor 2 antagonists
Figures from the paper
Abstract (AI)
ABSTRACT The regulation of glucagon and insulin secretion, from pancreatic α‐ and β‐cells, respectively, is essential for maintaining blood glucose within the physiological set point. Insulin secretion is stimulated as glucose rises from euglycemia, with incretin hormones modulating the secretion in a glucose‐dependent manner. Glucagon secretion is elevated with hypoglycemia but also with hyperglycemia. Within the pancreatic islet, α‐cell glucagon output is regulated by complex neuroendocrine and paracrine signals from insulin‐releasing β‐cells and somatostatin‐secreting δ‐cells. This network of intra‐islet crosstalk tunes glucagon secretion in response to changes in glucose levels. In diabetes, intra‐islet paracrine crosstalk between ‐, β‐, and δ‐cells is disrupted. Autoimmune destruction of β‐cells or impaired α‐cell responsiveness to residual β‐cell signals leads to hyperglucagonemia. Conversely, the loss of controlled insulin secretion, along with elevated somatostatin levels, attenuates glucagon responses to hypoglycemia or to prolonged exercise. Antihypoglycemia therapies such as selective somatostatin receptor 2 antagonists have emerged as a novel strategy in managing iatrogenic insulin‐induced hypoglycemia. This review summarizes the latest experimental findings on the regulation of glucagon secretion by pancreatic β‐ and δ‐cells, examines how this paracrine regulation of ‐cell secretion is affected in diabetes, and highlights potential interventions aimed at restoring physiological glucagon dynamics.
Key Findings
1
Diabetes disrupts intra-islet crosstalk, contributing to hyperglucagonemia through β-cell destruction or impaired α-cell responsiveness to residual β-cell signals.
2
Glucagon secretion rises during both hypoglycemia and hyperglycemia, requiring coordinated regulation alongside glucose-stimulated insulin secretion.
3
Loss of controlled insulin secretion and elevated somatostatin can blunt glucagon responses to hypoglycemia or prolonged exercise.
4
Pancreatic β- and δ-cells regulate α-cell glucagon output through complex intra-islet paracrine and neuroendocrine signaling.
5
Selective somatostatin receptor 2 antagonists are emerging as potential therapies for iatrogenic insulin-induced hypoglycemia by restoring glucagon responses.
Research Object
Pancreatic islet α-cells and their intra-islet interactions with β- and δ-cells
Research Subject
Paracrine regulation of glucagon secretion across hypoglycemia, euglycemia, and hyperglycemia, including its disruption in diabetes
Publication Details
Publication Date
2026-09-01
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest